A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2011
03/23/2011	CN101152546B Externally used preparations with functions of anti-inflammation, relieving itching and sterilization disinfection, and method for preparing the same
03/23/2011	CN101112417B Rheum defervescence liniment and method for preparing the same
03/23/2011	CN101091747B Preparation method of forsythia fruit and effective part, and new message
03/22/2011	US7910741 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
03/22/2011	US7910712 Fungal cell wall synthesis gene
03/22/2011	US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders
03/22/2011	US7910595 Anti-viral compounds
03/22/2011	US7910593 Water-soluble prodrugs
03/22/2011	US7910564 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant
03/22/2011	US7910562 Method of delivering genes into antigen presenting cells of the skin
03/22/2011	US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression
03/22/2011	US7910368 Method of extended culture for antigen-specific cytotoxic lymphocytes
03/22/2011	US7910144 Pet food composition for treating helicobacter species in pets
03/22/2011	US7910133 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
03/22/2011	US7910117 Vaccine
03/22/2011	US7910114 Methods of treating infectious diseases
03/22/2011	CA2521398C A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
03/22/2011	CA2500824C Tricyclic tetrahydroquinoline antibacterial agents
03/22/2011	CA2492342C Novel bio-active pyrimidine derivatives
03/22/2011	CA2484275C Warming and nonirritating lubricant compositions and method of comparing irritation
03/22/2011	CA2480273C Ph-sensitive polymer
03/22/2011	CA2471538C Pyrrolopyrimidines
03/22/2011	CA2461380C Hepatitis c virus vaccine
03/22/2011	CA2460036C Medical devices containing rapamycin analogs
03/22/2011	CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof
03/22/2011	CA2433675C Pharmaceutically active piperidine derivatives
03/22/2011	CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/22/2011	CA2359334C Bifidobacterium in the treatment of inflammatory disease
03/22/2011	CA2236159C Vp antigens of the jc virus
03/22/2011	CA2223013C Methods of raising antibodies against e.coli of the family cs4-cfa/1
03/22/2011	CA2136958C Method for inhibition of viral morphogenesis
03/17/2011	WO2011032100A1 Inhibitors of kshv vil6 and human il6
03/17/2011	WO2011032050A2 Gyrase inhibitors
03/17/2011	WO2011032000A2 Method for protection of antimicrobial and anticancer drugs from inactivation by nitric oxide
03/17/2011	WO2011031965A1 Modulators of toll-like receptors
03/17/2011	WO2011031926A1 Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyridyl)-1-[2-[4-pyridyl)ethyl]propanamide and uses thereof
03/17/2011	WO2011031850A1 New vaccine formulations comprising saponin-containing adjuvants
03/17/2011	WO2011031745A1 Antibacterial fluoroquinolone analogs
03/17/2011	WO2011031744A1 Antibacterial fluoroquinolone analogs
03/17/2011	WO2011031743A1 Antibacterial fluoroquinolone analogs
03/17/2011	WO2011031740A1 Antibacterial fluoroquinolone analogs
03/17/2011	WO2011031669A1 Inhibitors of flaviviridae viruses
03/17/2011	WO2011031471A2 The fungal srebp pathway as a target for anti-fungal agents
03/17/2011	WO2011031237A1 Phytochemical compositions including sesamin for anti¬ inflammatory, anti-cytokine storm, and other uses
03/17/2011	WO2011031236A1 Phytochemical compositions including xanthones for anti-inflammatory, anti-cytokine storm, and other uses
03/17/2011	WO2011031187A1 Antimicrobial agents based on hemin derivatives
03/17/2011	WO2011031073A2 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof
03/17/2011	WO2011030851A1 Process for production of natural killer cells
03/17/2011	WO2011030166A1 The use of lipid emulsions for binding hepatitus c virus
03/17/2011	WO2011029980A1 Therapeutic compositions for the treatment of hpv-induced diseases
03/17/2011	WO2011029460A1 Nonhygroscopic linezolid salts
03/17/2011	WO2011029404A1 Mir-125a for regulating expression of rantes, composition and use thereof
03/17/2011	WO2011029218A1 Use of montmorillonite in manufacture of medicaments
03/17/2011	WO2010144646A3 Anti-viral compounds to treat hcv infection
03/17/2011	WO2010136841A3 Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
03/17/2011	WO2010122367A3 Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
03/17/2011	US20110067142 Hybrid artichoke variety nun 4006 ar
03/17/2011	US20110066111 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
03/17/2011	US20110066101 Non-invasive ocular drug delivery
03/17/2011	US20110065795 (1s,2s,3s,4r)-3-[(1s)-1-acetylamino-2-ethyl-butyl]-4-uanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid hydrates pharmaceutical uses thereof
03/17/2011	US20110065776 Method for Treating Hepatitis C Infection
03/17/2011	US20110065773 Rna interference mediating small rna molecules
03/17/2011	US20110065766 Methods of use of antiviral compounds
03/17/2011	US20110065762 Methods of use of antiviral compounds
03/17/2011	US20110065760 Compounds for the inhibition of rotamases and use thereof
03/17/2011	US20110065758 Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions
03/17/2011	US20110065757 Methods for treatment of kallikrein-related disorders
03/17/2011	US20110065754 Iminosugars and methods of treating filoviral diseases
03/17/2011	US20110065753 Methods of treating poxviral infections
03/17/2011	US20110065752 Methods of treating orthomyxoviral infections
03/17/2011	US20110065742 Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high PH environments
03/17/2011	US20110065737 Hcv protease inhibitors
03/17/2011	US20110065732 Kit for topical application of medication
03/17/2011	US20110065723 Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]amino]-n-[3-(4-pyridyl)-1-[2-(4-pyridyl)ethyl]propyl]propanamide and uses thereof
03/17/2011	US20110065722 A crystalline form of posaconazole
03/17/2011	US20110065719 Pharmaceutical formulations containing flavouring substances with improved pharmaceutical
03/17/2011	US20110065718 Antifungal Product, Use and Formulation Thereof
03/17/2011	US20110065712 Tricyclic compounds and pharmaceutical uses thereof
03/17/2011	US20110065698 Novel protein kinase modulators
03/17/2011	US20110065687 Hydrazide compounds and uses thereof
03/17/2011	US20110065686 Chemical compounds having antiviral activity against dengue virus and other flaviviruses
03/17/2011	US20110065655 Therapeutic composition to treat lesions caused by herpes simplex virus
03/17/2011	US20110065631 Process for preparation of hiv protease inhibitors
03/17/2011	US20110065630 Use of a octreotide as a therapeutic agent
03/17/2011	US20110065146 Expression of HIV polypeptides and production of virus-like particles
03/17/2011	US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases
03/17/2011	US20110065109 Rna interference mediating small rna molecules
03/17/2011	US20110064813 Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet
03/17/2011	US20110064796 Concentrated, inhalable antibiotic formulation
03/17/2011	US20110064793 Inhibitors of hiv replication and method of treatment of hiv infections
03/17/2011	US20110064789 Docosahexanoic acid as inhibitor of h. pylori
03/17/2011	US20110064776 Dental composition containing organic nanotube
03/17/2011	US20110064772 Viral adjuvants
03/17/2011	US20110064768 Immunogenic Compositions
03/17/2011	US20110064767 Cdna construct of salmonidae alphavirus
03/17/2011	US20110064766 Attenuated Vaccine Against Fish Pathogen Francisella Sp.
03/17/2011	US20110064765 Pcv-2 vaccine
03/17/2011	US20110064764 Attenuated Live Triple G Protein Recombinant Rabies Virus Vaccine for Pre- and Post-Exposure Prophylaxis of Rabies
03/17/2011	US20110064763 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
03/17/2011	US20110064761 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof

1 ... 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 ... 1798